Abdelaal Ahmed H K, Sedky Mohamed, Gohar Seham, Zaki Iman, Salama Asmaa, Hassanain Omayma, El Ghoneimy Ahmed M
Consultant of Musculoskeletal Tumor Surgery, Children Cancer Hospital-Egypt (57357), 11617 Cairo, Egypt - Lecturer, Department of Orthopedic Surgery, Faculty of Medicine, Sohag University, 82524 Sohag, Egypt.
Professor of Pediatrics, Pediatric Department National Research Centre, Consultant of Pediatric Oncology Children Cancer Hospital-Egypt (57357), 11617 Cairo, Egypt.
SICOT J. 2020;6:28. doi: 10.1051/sicotj/2020024. Epub 2020 Jul 16.
Skeletal involvement in children with Langerhans cell histiocytosis (LCH) is a common feature of the disease. Several options for the treatment of these skeletal lesions have been reported. We describe our experience in the treatment of skeletal involvement of LCH in this retrospective case series study, entailing anatomic distribution, pattern of healing, skeletal deformities, and functional outcome of skeletal LCH.
A retrospective analysis was conducted for patients diagnosed with LCH and having skeletal lesions in the period between 2007 and 2015. Out of a total of 229 cases, 191 (83.4%) had skeletal involvement. Bone healing was divided into partial and complete based on the size of lesion and cortical changes in plain radiograph. Skeletal deformities were serially measured. Time to pain control, resumption of weight bearing, and the final functional status of the patient were reviewed.
The mean age at presentation was 4.4 years (3 m-14.8 y) and the mean follow-up period was 53.3 months (0.2-120.7). After screening of skeletal and extra-skeletal lesions, 59 patients (31%) had M-S (Multisystem) LCH and 132 (69%) had S-S (Single system) LCH. Unifocal bone lesions were found in 81 (42.5%) patients, and multifocal bone lesions in 110 patients (57.5%). Single or multiple bone lesions were found in the craniofacial bones in 152 patients (79.5%), femur in 19 patients, (10%), ribs in 18 patients (9.4%), spine in 15 patients (8.1%), pelvis in 14 patients (7.3%), scapula in 8 patients (4.1%), humerus in 6 (3.1%), clavicle in 6 patients (3.1%), tibia in 3 patients (1.5%), radius in 3 patients (1.5%), and the ulna in 2 patients (1%) patients. No lesions were found in the fibula, hand, or foot. Out of all skeletal lesions, 179 (93.7%) patients were treated either medically or conservatively and 12 patients (6.2%) were treated surgically. The mean time to complete healing was 5.2 months (2-12). Skeletal complications included: pathologic fractures (9 vertebra plana, 5 long bone, 1 iliac bone), deformities (9 thoracolumbar kyphosis, 2 cervical spine subluxations, 2 coxa vara deformity of the proximal femur and one flattening of iliac bone).
Non-operative treatment can lead to adequate bone healing in few months period. Partial or complete remodeling of bone deformities can be observed without surgical correction. However, surgical intervention might be indicated when cervical spine affection may lead to instability and subsequent neurological affection. Functional impairment is rarely caused by skeletal lesions in LCH.
朗格汉斯细胞组织细胞增多症(LCH)患儿的骨骼受累是该疾病的常见特征。已有多种治疗这些骨骼病变的方法被报道。在这项回顾性病例系列研究中,我们描述了我们在治疗LCH骨骼受累方面的经验,包括解剖分布、愈合模式、骨骼畸形以及骨骼LCH的功能结局。
对2007年至2015年期间诊断为LCH且有骨骼病变的患者进行回顾性分析。在总共229例病例中,191例(83.4%)有骨骼受累。根据平片上病变大小和皮质变化,将骨愈合分为部分愈合和完全愈合。对骨骼畸形进行连续测量。回顾疼痛控制时间、恢复负重时间以及患者的最终功能状态。
就诊时的平均年龄为4.4岁(3个月至14.8岁),平均随访期为53.3个月(0.2至120.7个月)。在筛查骨骼和骨骼外病变后,59例(31%)患者为多系统(M-S)LCH,132例(69%)为单系统(S-S)LCH。81例(42.5%)患者发现单灶性骨病变,110例(57.5%)患者发现多灶性骨病变。152例(79.5%)患者的颅面骨发现单处或多处骨病变,19例(10%)患者的股骨、18例(9.4%)患者的肋骨、15例(8.1%)患者的脊柱、14例(7.3%)患者的骨盆、8例(4.1%)患者的肩胛骨、6例(3.1%)患者的肱骨、6例(3.1%)患者的锁骨、3例(1.5%)患者的胫骨、3例(1.5%)患者的桡骨以及2例(1%)患者的尺骨发现骨病变。腓骨、手部或足部未发现病变。在所有骨骼病变中,179例(93.7%)患者接受了药物或保守治疗,12例(6.2%)患者接受了手术治疗。完全愈合的平均时间为5.2个月(2至12个月)。骨骼并发症包括:病理性骨折(9例椎体扁平、5例长骨、1例髂骨)、畸形(9例胸腰椎后凸、2例颈椎半脱位、2例股骨近端髋内翻畸形和1例髂骨扁平)。
非手术治疗可在数月内实现充分的骨愈合。无需手术矫正即可观察到骨畸形的部分或完全重塑。然而,当颈椎受累可能导致不稳定及随后的神经受累时,可能需要手术干预。LCH的骨骼病变很少导致功能障碍。